Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
10.85
-0.24 (-2.16%)
At close: May 19, 2026, 4:00 PM EDT
10.73
-0.12 (-1.11%)
After-hours: May 19, 2026, 7:34 PM EDT
Delcath Systems Revenue
Delcath Systems had revenue of $24.99M in the quarter ending March 31, 2026, with 26.33% growth. This brings the company's revenue in the last twelve months to $90.44M, up 67.95% year-over-year. In the year 2025, Delcath Systems had annual revenue of $85.23M with 129.08% growth.
Revenue (ttm)
$90.44M
Revenue Growth
+67.95%
P/S Ratio
4.14
Revenue / Employee
$579,750
Employees
156
Market Cap
374.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 85.23M | 48.03M | 129.08% |
| Dec 31, 2024 | 37.21M | 35.14M | 1,701.69% |
| Dec 31, 2023 | 2.07M | -654.00K | -24.05% |
| Dec 31, 2022 | 2.72M | -836.00K | -23.52% |
| Dec 31, 2021 | 3.56M | 1.91M | 115.98% |
| Dec 31, 2020 | 1.65M | 66.00K | 4.18% |
| Dec 31, 2019 | 1.58M | -1.83M | -53.62% |
| Dec 31, 2018 | 3.41M | 692.00K | 25.49% |
| Dec 31, 2017 | 2.72M | 723.00K | 36.30% |
| Dec 31, 2016 | 1.99M | 245.00K | 14.02% |
| Dec 31, 2015 | 1.75M | 678.00K | 63.42% |
| Dec 31, 2014 | 1.07M | 279.00K | 35.32% |
| Dec 31, 2013 | 790.00K | 98.00K | 14.16% |
| Dec 31, 2012 | 692.00K | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 857.50M |
| Viemed Healthcare | 286.57M |
| Cytek Biosciences | 204.17M |
| Pacific Biosciences of California | 160.03M |
| Beta Bionics | 110.24M |
| Standard BioTools | 86.26M |
| Electromed | 71.75M |
| ClearPoint Neuro | 40.61M |
DCTH News
- 4 days ago - Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 days ago - Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference - Business Wire
- 12 days ago - Delcath Systems presents new data on M-PHP at ESMO - TheFly
- 12 days ago - Delcath Systems reports Q1 EPS (3c), consensus (9c) - TheFly
- 12 days ago - Delcath Systems backs FY26 revenue view at least $100M, consensus $102.69M - TheFly
- 12 days ago - Delcath Systems Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - Delcath Systems Earnings release: Q1 2026 - Filings
- 12 days ago - Delcath Systems Quarterly report: Q1 2026 - Filings